Membrane microviscosity, phospholipid composition, and turnover were measured in cultured vascular smooth muscle cells isolated from mesenteric arteries of stroke-prone spontaneously hypertensive and age-matched, normotensive Wistar-Kyoto rats. Membrane microviscosity, measured with fluorescence polarization, revealed greater microviscosity (lower fluidity) of the membranes isolated from smooth muscle cells from hypertensive as compared with those isolated from normotensive rats (p<0.01). Preincubation of membranes from hypertensive rats with 5 mM calcium reduced membrane microviscosity in "core" and in "surface" regions of the bilayer toward values observed in Wistar-Kyoto rats. Phospholipid composition did not differ between intact aortas and cultured mesenteric cells or between those tissues obtained from normotensive and from hypertensive rats. The total lipid-associated radioactivity was significantly lower in cells from stroke-prone spontaneously hypertensive rats than in those from Wistar-Kyoto controls (/?<0.01). Phosphatidylcholine incorporated 70% and phosphatidylinositol 16% of total lipid-associated radioactivity, with no difference between cells from hypertensive and normotensive animals. Turnover of phosphatidylethanolamine was greater in cells from Wistar-Kyoto rats (p=0.02), whereas turnover of phosphatidylserine was greater in cells from stroke-prone spontaneously hypertensive rats (p=0.04). The greater microviscosity of the lipid bilayer in hypertension is a generalized defect of the matrix in which the transport proteins function. We hypothesize that this defect is responsible for the multiple abnormalities of membrane transport systems that have been described in genetic hypertension. (Hypertension 1991;18:748-757)
H ypertension has been associated with abnormalities in many membrane transport systems including channels for sodium and potassium 1 
"
3 and calcium, 4 exchangers for sodium/ hydrogen 56 and for sodium/calcium, 7 as well as active pumps for sodium/potassium 78 and for calcium. 910 The diversity of the membrane proteins that have been found to have abnormal functions in hypertension led to the hypothesis that this generalized dysfunction of diverse protein transport systems is caused by a fault in the matrix in which they all function, the lipid bilayer.
11
There is extensive evidence that the functions of membrane proteins are influenced by properties of the lipid bilayer. 12 For example, Remmers et al 13 have observed that the opioid receptor can be modulated by specific fatty acids through mechanisms involving membrane fluidity. In addition, the coupling of the /3-adrenergic receptor to adenylate cyclase is enhanced by decreasing membrane microviscosity, 14 and Na + , K + -ATPase activity is accelerated when the membrane microviscosity is low. 15 Fluorescence polarization studies in erythrocytes and platelets from patients with essential hypertension and from spontaneously hypertensive rats (SHR) showed increased microviscosity as compared with normotensive controls. 16 - 19 Tsuda et al, 20 using an electron spin resonance and spin-labeling method, confirmed decreased membrane fluidity in erythrocytes and cultured vascular smooth muscle cells (VSMC) of SHR. The physicochemical properties such as microviscosity of biomembranes are affected by the content and physiological states of cholesterol, phospholipids, and their fatty acids. 15 Okamoto et al 21 have shown that renal membrane phospholipids, especially phosphatidylcholine and phosphatidylethanolamine, decrease with age in SHR. This decrease is associated with increased phospholipase A 2 activity and phospholipid degradation.
The majority of studies of lipid bilayer composition and its functional properties in hypertension have been performed on circulating blood cells. There is very little information on lipid bilayer in VSMC. This tissue is relevant since it is directly involved in the increased vascular reactivity and medial hypertrophy, hallmarks of the hypertensive process. The purpose of this study is to compare membrane microviscosity, phospholipid composition, and metabolism in VSMC from stroke-prone SHR (SHRSP) and from Wistar-Kyoto normotensive rats (WKY).
Methods

Animals
SHRSP and WKY rats were obtained from colonies in the Department of Anatomy and Cell Biology at the University of Michigan. These are inbred colonies, derived from a stock supplied by the National Institutes of Health (NIH), Bethesda, Md. Data on age, weight, and blood pressure of rats are given in Table 1 . Rats were decapitated and the mesenteric arteries and thoracic aortas were removed under aseptic conditions and were placed in ice-cold Hanks' balanced salt solution (HBSS). Aortas (five per preparation) were cleaned of fat and adventitia and immediately were frozen by placing in aluminum foil over a mixture of dry ice and acetone. Aortas were stored in -70°C before the lipid extraction procedure.
Isolation and Culture of Rat Mesenteric Artery Smooth Muscle Cells
VSMC were harvested from enzymatically dissociated rat mesenteric arteries by modifications of the methods described by Gunther et al 22 and Lyall et al. 23 All procedures were carried out under aseptic conditions. The superior mesenteric artery with its major branches was excised, en bloc, from its origin at the aorta to the mesenteric border of the intestine and was placed in a petri dish containing ice-cold HBSS with 0.2 mM added Ca 2+ . Fat, adventitia, and veins were removed by blunt dissection, the branches were cut off close to the main trunk of the superior mesenteric artery, and the artery was cut open lengthwise to expose the endothelial layer. The cleaned mesenteric arteries (five per preparation) were transferred into a petri dish containing 5 ml enzyme dissociation mixture: HBSS with 0.2 mM added Ca 2+ , 1.25 mg/ml collagenase, 0.25 mg/ml elastase, 0.5 mg/ml soybean trypsin inhibitor, and 2 mg/ml bovine serum albumin. The arteries were incubated at 37°C in a humidified 5% CO2-95% air atmosphere for approximately 30 minutes. Then the arteries were transferred to fresh HBSS and triturated 10 times through a plastic Pasteur pipette. They were cut into small pieces, transferred to fresh enzyme dissociation mixture, and incubated at 37°C with periodic trituration until a single cell suspension was obtained (usually 45-60 minutes). The tissue suspension was sieved through 106-^.m stainless steel mesh to separate dispersed cells from undigested vessel wall fragments and debris. The filtered suspension was diluted in 20 ml Dulbecco's modified Eagles medium (DMEM) supplemented with 10% (vol/vol) fetal bovine serum, 10% (vol/vol) equine serum, 2 mM L-glutamine, 100 units/ml penicillin, and 100 jig/ml streptomycin and then was centrifuged (400g, 5 minutes). The cell pellet was resuspended in 5 ml DMEM supplemented as described above. The dispersed cells were plated in a 25-cm 2 culture flask and were maintained in a humidified atmosphere of 5% CO 2 -95% air at 37°C.
After the first 24 hours, the medium was replaced to remove nonadherent cells. Plating efficiency was consistently above 50%. Medium was changed at 48-72-hour intervals. VSMC had usual growth characteristics, took 7 days to reach confluence after plating, and at confluence, had the typical "hill and valley" pattern. 22 Cells up to the 10th passage were harvested once a week with trypsin-EDTA and passaged at a 1:3 ratio in 162-cm 2 flasks. Before experiments, cells were deprived of serum by a 24-48-hour incubation in fresh DMEM supplemented with 0.4% fetal calf serum. The cells were positively identified as smooth muscle by indirect immunofluorescent staining for a-actin. To detect the presence of smooth muscle-specific a-actin, the cells grown to 50% confluence on sterilized round cover slips, 12-mm diameter, were fixed in acetone: methanol (1:1, vol/vol) for 2 minutes at -20°C. They were then incubated with monoclonal anti-a-smooth muscle actin antibody diluted 1:400 in phosphate-buffered saline (PBS) with 1% bovine serum albumin for 60 minutes at 37°C. After washing three times in PBS of the same composition, the cells were incubated with secondary antibody-anti-mouse immunoglobulin G (IgG) (whole molecule) fluorescein isothiocyanate (FITC) conjugate in the dark for 45 minutes at 37°C. After being washed three times in PBS, cover slips were mounted onto microscope slides on glycerol 9:1 (vol/vol) in PBS and examined under a fluorescence microscope at a magnification of x400 and x630. NIH-3T3 cells (mesenchymal cell line; gift from Dr. Donald MacCallum) and VSMC incubated with secondary antibody only were used as controls. An example of the immunofluorescence study of mesenteric cells at the stage of second passage is shown in Figure 1 .
Membrane Preparation
Confluent monolayers of VSMC were washed three times with ice-cold HBSS (Ca 2+ , Mg
2+
-free formula) and detached by gentle scraping with the aid of a "rubber policeman." The suspension was centrifuged for 5 minutes at 400g, and the pellet was suspended in hypotonic buffer of the following composition (mM): Na 2 0.2, dithiothreitol 1, pH 7.4. The pellet was then dispersed in a Dounce homogenizer and was centrifuged for 15 minutes at 20,000g, 4°C. The resulting pellet was resuspended in 50 mM Tris HC1, pH 7.4, at a protein concentration of 1 mg/ml.
Determination of Protein
The methods used were according to Lowry et al 24 and Bradford 25 with bovine serum albumin as a standard. The membrane protein was solubilized initially with 1M NaOH-for 30 minutes at 25°C.
Measurement of Membrane Microviscosity
A previously described method 13 was applied, except in our study both fluorophores were measured at the same wavelengths for excitation and emission, respectively. The fluorescent probes diphenylhexatriene (DPH) (solution in Af,JV-dimethylformamide) and its charged trimethylammonium derivative (TMA-DPH) (solution in tetrahydrofuran) were incubated with membranes at 25°C for 30 minutes and 60 minutes, respectively. The molar ratio of probe to membrane phospholipid was approximately 1:200 in all experiments. It was determined that this ratio of probe to membrane phospholipid did not perturb membrane microviscosity. Fluorescence polarization was measured in a spectrofluorometer (SLM Instruments, Inc., Urbana, 111.) at wavelengths of 340 nm for excitation and 450 nm for emission. The results are expressed as anisotropy units (r), where r=(l fl -l gfl )(l fl +21 90 ) and IQ and 1% represent the intensities of light when polarizers were in parallel or perpendicular orientation, respectively. Differences in the efficiency of transmitting vertically and horizontally polarized light were corrected for by determining the polarization ratio (l 0 -lgo) using horizontally rather than vertically polarized excitation light. The advantage of expressing fluorescence polarization as anisotropy is the additive nature of the latter. 13 
Phospholipid Composition of Cultured Vascular Smooth Muscle Cells and Intact Aortas
Confluent monolayers of VSMC were washed three times with ice-cold physiological salt solution (PSS) of the following composition (mM): NaCl 130, KC1 4-7, KH 2 PO 4 1.18, MgSO 4 -7H 2 O 1.17, CaCl 2 -2H 2 O 1.6, NaHCO 3 14.9, dextrose 5.5, CaNa 2 -EDTA 0.026. The cells were scraped into 15-ml ice-cold PSS and were centrifuged at 400g for 5 minutes. Lipid extraction was performed as described by Lee and Hajra. 26 In brief, cell pellets and intact aortas were homogenized three times for 30 seconds each at 2.5 setting, in chloroform: methanol (1:1, 12 ml/g of tissue) with a Polytron homogenizer (Brinkmann Instruments, Inc., Westbury, N.Y.). The homogenate was centrifuged (l,000g, 10 minutes), and the supernatant was saved. The residue was dispersed in water (0.5 ml/g tissue) by agitation in a sonic bath, and this dispersed residue was rehomogenized in chloroform: methanol (1:1, 6 ml/g original tissue). This second homogenate was centrifuged (l,000g, 10 minutes), and the supernatant was combined with the first supernatant. To the combined supernatants, an additional amount of chloroform was added (9 ml/g tissue) and mixed well, and 0.9% aqueous NaQ (5.5 ml/g tissue) was added to the extract to facilitate the separation. The mixture was vortex-mixed and centrifuged (l,000g, 5 minutes), and the upper layer was removed. The lower layer was dried under a stream of nitrogen at 40°C and resuspended in 100 fi\ chloroform: methanol (2:1, vol/vol). The phospholipids were resolved by monodimensional thin-layer chromatography (TLC) using the following solvent systems: 1) chloroform:methanol:0.25% aqueous KC1:ethyl acetate: isopropanol (60:18:12:36:50, vol/vol); 2) chloroform : methanol: acetic acid:H 2 O (100:40:12:4, vol/ vol); and 3) chloroform: methanol: 40% methylamine (63:35:10, vol/vol). The individual phospholipids, cochromatographed with standards and visualized with primuline, were identified and scraped for phosphate determination performed according to Ames. 27 Samples of scraped phospholipids and K 2 HPO 4 standards were mixed with 10% Mg(NO 3 ) 2 in 95% ethanol, dried and heated in a flame until brown vapor disappeared. After cooling, 0.5N HC1 (0.3 ml) was added, and samples were heated in a heating block at 100°C for 15 minutes. This was followed by incubation with 0.7 ml of a mixture of 10% ascorbic acid: 0.42% ammonium molybdate in IN H 2 SO 4 (1:6, vol/vol) for 30 minutes at 45°C. The concentration of phosphate was determined spectrophotometrically (Beckmann, DU70, Arlington Heights, 111.) at 820 nm. The results are expressed as a percentage of total phospholipid content in each lipid extract.
Isolation of Platelets
Washed platelets were prepared as described previously. 28 Briefly, platelet-rich plasma was prepared by centrifuging citrated (1 ml of 3.9% [wt/vol] sodium citrate/9 ml of blood) whole blood at 400g for 5 minutes at room temperature. EGTA (5 mM) was added to the platelet-rich plasma, which was centrifuged at 40Qg for 10 minutes. The supernatant was removed, and the pellet was suspended in calciumpoor medium containing (mM) NaCl 130, KC1 4.7, MgCl 2 1, glucose 10, HEPES 20, pH 7.4. The platelets were counted in a Coulter counter (Coulter Corp., Hialeah, Fla.) and the concentration of platelets adjusted to 1.5-2xlO 8 /ml.
Labeling of Phospholipids in Vascular Smooth Muscle Cells and Platelets
VSMC were trypsinized and pelleted at 400g for 10 minutes. The pellet was resuspended in HEPES buffer of the following composition (mM): NaCl 130, KC1 4.7, MgCl 2 1, glucose 10, HEPES 20, CaCl 2 1.6, pH 7.4. Aliquots of the VSMC (or platelet) suspension (0.58 ml each) were incubated with 0.02 mCi phosporus-32 for 0, 30, 60, 120, and 180 minutes at 37°C in a shaking water bath. Platelets were incubated in calcium-poor medium as described above. The reaction was terminated by addition of 2.25 ml chloroform: methanol (1:2, vol/vol). The phospholipids were extracted under acidic conditions according to the method of Bligh and Dyer (as modified by LaBelle and Hajra 29 ). The lower layer was evaporated to dryness under a stream of nitrogen at 40 c C, and phospholipids were separated by TLC using solvent system of chloroform: methanol: 40% methylamine (63:35:10, vol/vol). Individual phospholipids were localized by overnight (12-14 hours) autoradiography (Kodak X-OMAT film), and 32 P incorporation was quantified by scraping the phospholipid spots from the silica plate and counting in the scintillation counter.
Statistical Analysis
Data are presented as the mean±SEM of n experiments (five animals were used for each tissue/cell culture preparation). Statistical analysis was performed using the unpaired Student's t test with Bonferroni correction for multiple comparisons. A value ofp < 0.05 was regarded as a significant difference.
Materials
Phosphatidylcholine, phosphatidylinositol, phosphatidylserine, phosphatidylethanolamine, phosphatidic acid, sphingomyelin, collagenase (type II), elastase (type IV), soybean trypsin inhibitor (type I-S), fetal bovine serum, equine serum, monoclonal anti-asmooth muscle actin, and anti-mouse IgG (whole molecule) FITC conjugate were obtained from Sigma Chemical Co., St. Louis, Mo. DPH and its charged derivative TMA-DPH were purchased from Molecular Probes, Junction City, Ore. Carrier-free 
Results
Membrane Microviscosity in Vascular Smooth Muscle Cells
Measurements with the membrane "core" probe DPH and "surface" probe TMA-DPH revealed significant difference in microviscosity between membranes obtained from SHRSP cells and those obtained from WKY cells (Figure 2 ). This difference was slightly greater for core than for surface probe measurements. Preincubation of VSMC membranes with 5 mM calcium, added to Tris buffer 30 minutes before fluorescent probes, significantly reduced membrane microviscosity in VSMC from SHRSP for DPH and TMA-DPH measurements. Membrane microviscosity in VSMC from WKY was also slightly reduced, but only the value for TMA-DPH reached statistical significance (Figure 2 ).
Phospholipid Composition
Phosphatidylcholine was the major phospholipid in cultured vascular smooth muscle cells and in intact aortas (approximately 40% of total phospholipid con- tent). No significant differences were observed in phospholipid composition between mesenteric VSMC and intact aortas. There was also no difference between vascular tissue or cells obtained from SHRSP and those obtained from WKY ( Figure 3 ). P into phosphatidylinositol and phosphatidylserine also tended to be lower in cells from SHRSP than in those from WKY, but these differences did not reach statistical significance at any time point ( Figure 5D ).
Phosphorus-32 Labeling of Phospholipids in Vascular
The total lipid-associated 32 P radioactivity was significantly lower in cells from SHRSP than in those from WKY after 60, 120, and 180 minutes of incubation ( Figure 5A ). The deficit in total lipid-associated 32 P observed in VSMC from SHRSP indicates that this tissue has a generalized defect in its mechanism for incorporating exogenous phosphate into lipids. To determine whether there were also differences among the phospholipids in their uptakes of 32 P, the results for individual phospholipid classes were expressed as percentages of total lipid-associated radioactivity after 2 hours of incubation ( Table 2) .
The phosphatidylcholine incorporated approximately 70% of the 32 P, and there was no significant difference in 32 P labeling between cells from SHRSP and WKY (Table 2) . Phosphatidylinositol incorporated approximately 16% of the 32 P, and again no significant difference was observed between the two cell types. Phosphatidylethanolamine that incorporated relatively much less radiolabeled phosphorus retained the original differential labeling with cells from WKY incorporating 6.2±0.7% 32 P into phosphatidylethanolamine and cells from SHRSP incorporating 4 ±0.4% 32 P into phosphatidylethanolamine (p=0.02; Table 2 ). In con- therefore repeated studies as we had done on VSMC in two experiments on platelets. Results of these two experiments were similar ( Table 2 ). The autoradiogram of one such experiment is presented in Figure  6 . Spots unambiguously identified as phosphatidylcholine were present on autoradiograms of platelet phospholipids from SHRSP and WKY. The 32 P incorporation into phosphatidylcholine was greater in platelets from SHRSP than in those from WKY ( Figure 6 and Table 2 ). The pattern of 32 P uptake by the individual phospholipids in platelets is entirely different from that in VSMC. This difference is evident in Table 2 in which 32 P uptake of the two platelet experiments is compared with the mean uptake values for eight VSMC studies. The uptake value for each phospholipid is expressed as the percentage of total lipid-associated radioactivity.
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FIGURE 5. Line graphs show time course of phosphorus-32 incorporation in phospholipids of vascular smooth muscle cells from Wistar-Kyoto rats (WKY) and stroke-prone spontaneously hypertensive rats (SHRSP). PL, total phospholipids; PC
Discussion
The major finding of this study is that membrane microviscosity, as measured with DPH the core or TMA-DPH the surface probe, was significantly greater in membranes from cultured VSMC obtained from SHRSP than in those obtained from the WKY normotensive control strain. Moreover, membrane microviscosity was modified in vitro by incubating the membranes with 5 mM calcium. This treatment significantly lowered microviscosity of SHRSP membranes in core and surface regions of the bilayer, making these membranes very similar to those obtained from VSMC from normotensive controls.
Early studies on membrane microviscosity in genetic hypertension were limited to membranes of circulating blood cells (red blood cells and platelets) and to measurements with the membrane core probe DPH. Studies with red blood cells involved only the plasma membrane, whereas in our studies with VSMC, both plasma membrane and intracellular membranes were isolated. Nevertheless, these earlier studies of red blood cells of SHR 1617 - 32 or of patients with essential hypertension 1819 demonstrated increased microviscosities of the same order of magnitude as that in our current data.
Devynck et al 33 reported similar changes in microviscosity in the plasma membranes of hepatocytes, synaptosomes, and cardiomyocytes of SHR. Tsuda et al, 20 using an entirely different methodology, an electron spin resonance found that values of outer hyperfine splitting and of the order parameter determined from electron spin resonance spectra for fatty acid spin-label agent (5-nitroxy stereate) were significantly higher in red blood cells and cultured VSMC from SHR than in those from WKY rats. These data were interpreted as indicating a decreased membrane fluidity in the SHR. The same group 34 showed that the red blood cells pretreated with the calcium ionophore A23187 and 1 mM calcium chloride had increased microviscosity as compared with the untreated cells. These changes were more prominent in the red blood cells from hypertensive rats and patients with essential hypertension than in their respective normotensive controls. The authors argued that an abnormality of cellular calcium handling might affect physicochemical properties of the biomembranes in hypertension. 34 The current study is the first fluorescence polarization study showing increased microviscosity of VSMC membranes from genetically hypertensive rats. Our findings demonstrate that the microviscosity of the hydrophobic core of the lipid bilayer of cultured VSMC from genetically hypertensive rats is greater than that of these cells from normotensive controls. This is the first experimental evidence indicating that there is a similarly greater microviscosity in the surface region of the bilayer of any cell isolated from genetically hypertensive rats. The hydrophilic surface of the bilayer consists of the polar heads of the phospholipids, and in all membranes it has a greater viscosity (lower fluidity) than does the central core, which consists of the acyl chains. Our observation that the microviscosity is greater in both the surface and the core regions suggests that the abnormality of the lipid bilayer in hypertension is generalized and therefore has the potential for affecting the function of transport proteins. In line with these findings is the frequently reported observation that membrane permeability to Na + , K + , and Ca 2+ is increased in hypertension. 1 -4 The possibility that the increased microviscosity may be the cause of these greater cation fluxes in hypertension is supported by observations of the effects of increased extracellular calcium concentration on membrane microviscosity and on cation fluxes. In the current study, we observed that an increase in calcium concentration decreases microviscosity of the lipid bilayer of VSMC from SHRSP.
Jones and Hart
35 and Furspan and Bohr 3 studied the effects of the same magnitude of increase in extracellular calcium concentration on potassium efflux from vascular smooth muscle and from lymphocytes, respectively. They found that the increase in extracellular calcium concentration caused a decrease in potassium efflux (i.e., calcium affected the membrane in such a way that the protein channel responsible for potassium efflux became less active). Their studies demonstrated that a concentration of 5 mM calcium had clear depressing effects on monovalent cation fluxes and on vascular reactivity. We therefore chose this concentration (5 mM) for our study of the effect of calcium on membrane microviscosity. These observations suggest that under conditions of hypertension or high extracellular calcium, membrane microviscosity may have an effect on cation fluxes. The increased microviscosity of hypertension is accompanied by an increase in cation fluxes, whereas when microviscosity is reduced by increasing extracellular calcium, the cation fluxes are depressed.
Bialecki and Tulenko 36 have studied the effects of another intervention and reported observations that give further support to this relation between membrane microviscosity and permeability. They observed that increased incorporation of cholesterol into VSMC membrane caused an increase in membrane permeability to calcium. Cholesterol is known to increase membrane microviscosity. 3738 Thus, cholesterol, which increases microviscosity, causes an increase in permeability as in hypertension; whereas calcium, which reduces microviscosity, causes a decrease in permeability to levels similar to those of normotensive rat.
Data from two laboratories documented that the cell membrane of various tissues from hypertensive humans and from the SHR binds less calcium than do tissues from normotensive controls.
3339 - 41 The molecular basis for this abnormality might be related to deficiency in calcium binding proteins or abnormalities of negatively charged phospholipids. Kowarski et al 42 have reported that various tissues from SHR contain less of an integral calcium binding protein than those from WKY. However, the affinity of this protein for calcium is too high: the binding sites would be saturated at physiological concentrations of extracellular calcium. This leaves the phospholipids of the lipid bilayer, particularly the negatively charged phosphatidic acid, phosphatidylserine, and phosphatidylinositol as the most important components that bind calcium, especially at low affinity sites. 38 -43 Contrary to our observation that membrane microviscosity is decreased by an elevated calcium concentration, several investigators have reported that calcium causes an increased microviscosity. 44 - 46 For example, Sauerheber et al 44 reported that incubation of rat epididymal adipocyte ghosts with calcium chloride decreased membrane fluidity in a concentration-dependent manner. We have no clear explanation for the difference between these results and ours except the very different cell type studied and different methodology of fluidity measurements: whole cell electron spin resonance versus membranes and polarization spectrofluorometry. The interaction of calcium with the membrane has been shown to affect phase separation, bilayer-nonbilayer transition, changes in membrane permeability, and fusion. 37 -38 Calcium may also provide bridging between proteins and lipids, which could exert a marked effect on the membrane assembly. 38 It is clear that there are many tenable alternatives to our speculation relating calcium "stabilization" to bilayer microviscosity.
We carried out studies to determine whether these clear differences in membrane microviscosity and permeability between VSMC of WKY and SHRSP could be caused by differences in phospholipid composition or their dynamic properties within the lipid bilayer. Direct measurements of phospholipid composition in cultured VSMC and in intact aortas demonstrated a similarity between the two vascular preparations, suggesting that this property of the membrane had not undergone a phenotypic change in culture. There was no difference in the content of major classes of phospholipids between VSMC from SHRSP as compared with those from WKY rats. This is in agreement with data on phospholipid composition in platelets 30 and thoracic aortas 47 from SHR and WKY. The authors of the latter study measured only phosphatidylethanolamine and phosphatidylcholine content.
Okamoto et al 21 presented evidence for increased activity of phospholipase A 2 in renal membranes of SHRSP as compared with WKY. This phospholipase activity increased with age in SHRSP and was associated with parallel decreases of phosphatidylcholine, phosphatidylethanolamine, and of the phosphatidylcholine-to-sphingomyelin ratio. Phosphatidylcholine and phosphatidylethanolamine act as membrane fluidizers, whereas proteins, cholesterol, and sphingomyelin act as rigidifiers. 37 Okamoto et al 21 speculated therefore that the renal membrane of SHRSP became "rigid" with age due to the changes in phospholipid composition.
The method used in the current study permitted the determination of phosphate content with precision to 0.01 /umol, 27 and no difference was observed between those measurements in VSMC from WKY and from SHRSP. It should be stressed, however, that under physiological conditions, lipid constituents of biological membranes diffuse freely in the plane of the membrane. Another feature that adds to this complexity is the asymmetric distribution of phospholipids in the endofacial and the exofacial sides of the membrane. 37 It might therefore be more relevant, for pathophysiological considerations, to measure lipid microviscosity rather than the chemical composition of the phospholipids within the bilayer.
Remmal et al 30 and Marche et al 31 presented evidence for enhanced turnover of phosphatidylcholine in platelets of SHR, SHRSP, and inbred Dahl salt-sensitive rats as compared with their respective normotensive control strains. In contrast, platelets from deoxycorticosterone acetate (DOCA)-salt hypertensive rats showed similar 32 P phosphatidylcholine labeling as their normotensive controls. It was argued that the enhanced turnover of the most abundant membrane phospholipid may constitute a primary membrane alteration, ultimately resulting in increased free cytosolic calcium and increased sensitivity to agonists. 31 The current experiments, examining 32 P labeling of individual phospholipids in VSMC, gave results that differed from those obtained in platelets.
3031 VSMC from both sources exhibited a major radioactive spot identified as phosphatidylcholine. The total lipidassociated radioactivity was greater in VSMC from WKY than in those from SHRSP. The possible role of the different metabolic pools of ATP or lack of the isotopic equilibrium with the y-phosphate of the ATP, or both, cannot be excluded as the basis for this difference. Insight into differences that may occur between WKY and SHRSP phospholipids can be obtained by expressing the 32 P labeling of the individual phospholipids as a percentage of total lipidassociated radioactivity after incubation with the isotope.
3048 After 2 hours of incubation, phosphatidylcholine labeling was similar in cells from SHRSP and WKY, whereas 32 P incorporation into phosphatidylethanolamine was significantly greater in cells from WKY than in those from SHRSP. Phosphatidylethanolamine has been shown to act as membrane fluidizer 37 and to affect the activity of Ca 2+ ATPase possibly through interactions between the bilayer surface and the extramembranous portions of the calcium pump protein. 15 There was also a small but significant difference in 32 P labeling of phosphatidylserine, which similar to phosphatidylethanolamine, is located in the inner half of the bilayer. It might be relevant that the calcium phospholipid-dependent protein kinase C requires phosphatidylserine for activation and that mesenteric arteries from SHRSP have been shown to be more responsive to the contractile effects of protein kinase C activators than those from WKY. 49 The observed discrepancies in 32 P labeling between VSMC in this study and platelets 30 -31 may be related to individualities of the cell types. However, because of this difference in labeling between VSMC in our laboratory and platelets as studied by Marche et al, 31 we felt that it was incumbent on us to repeat the platelet studies in our laboratory. Marche observed that after 2 hours of incubation with 32 P, platelets from SHRSP but not those from WKY exhibited radioactive spots identified as phosphatidylcholine. In contrast to this observation, our autoradiograms showed radioactive spots identified as phosphatidylcholine in platelets from SHRSP and WKY at each time point studied (see Figure 6) . Counting of the radioactivity in these spots confirmed Marche's observation that more 32 P was incorporated into phosphatidylcholine in SHRSP, but the differences observed in the current study were less pronounced than the 10-to 16-fold difference reported previously. 31 The explanation for these discrepancies is not clear; the possibilities to consider are: 1) betweenstrain differences in genetically hypertensive rats obtained from commercial suppliers as compared with inbred colonies used in this study 50 and 2) time of exposure of the x-ray film to TLC plates; the total lipid-associated radioactivity per microgram of protein tends to be low in platelets and longer exposure (up to 48 hours) is needed to visualize the phosphatidylcholine in platelets from WKY.
In conclusion, this is the first fluorescence polarization study to establish that membrane microviscosity of VSMC is elevated in SHRSP as compared with membranes from WKY. It confirms observations on membranes from red blood cells and platelets suggesting that this bilayer abnormality may be generalized. More importantly, the current observation was made in a tissue that is involved directly in vascular contractility and thus in regulation of blood pressure. Our observations also demonstrate for the first time that the abnormality affects similarly the core and the surface regions of the lipid bilayer. In addition, we observed that an increase in calcium concentration causes a decrease in membrane microviscosity in both regions. Since an increase in extracellular calcium concentration also has been shown to decrease membrane permeability, we hypothesize that the increased microviscosity of the cell membrane in hypertension causes the increase in membrane permeability to K + , Na + , and Ca 2+ observed in hypertension.
